Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $306

Benzinga · 3d ago
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $307 to $306.